CYP3A5 and hepatocellular carcinoma: Both rs2740574 (an upstream polymorphism of CYP3A41B) and rs776746 (affecting CYP3A5 RNA splicing) influence the expression of CYP3A, thereby affecting the variability of AFB1-epoxide adducts in HCC patients [50].